Home Newsfeeds Citigroup Downgrades Varonis Systems to Neutral, Announces $21 Price Target

Citigroup Downgrades Varonis Systems to Neutral, Announces $21 Price Target

Citigroup analyst Fatima Boolani downgrades Varonis Systems (NASDAQ:VRNS) from Buy to Neutral and announces $21 price target.

byBenzinga Newsdesk

November 1, 2022

1 minute read

Citigroup analyst Fatima Boolani downgrades Varonis Systems (NASDAQ:VRNS) from Buy to Neutral and announces $21 price target.

Psychedelics Production Methods Expect Further IP Protection With 4 New Patents

By Lara Goldstein

December 7, 2:02 PM

Biotech company PsyBio Therapeutics Corp. (OTCQB: PSYBF) has filed four new U.S. Patent Cooperation Treaty (PCT) applications aiming to convert five provisional patent applications.

PSYBF

Criteo Q4 Adj. EPS $0.84 Misses $0.97 Estimate, Sales $283.40M Beat $277.28M Estimate

By Benzinga Newsdesk

February 8, 8:04 AM

Criteo (NASDAQ:CRTO) reported quarterly earnings of $0.84 per share which missed the analyst consensus estimate of $0.97 by 13.4 percent. This is a 41.67 percent decrease over earnings of $1.44 per share from the same

CRTO